These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1334824)
21. Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine. Flores-Aguilar M; Huang JS; Wiley CA; De Clercq E; Vuong C; Bergeron-Lynn G; Chandler B; Munguia D; Freeman WR J Infect Dis; 1994 Mar; 169(3):642-7. PubMed ID: 8158041 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of topical immunoglobulins against experimental adenoviral ocular infection. Nwanegbo EC; Romanowski EG; Gordon YJ; Gambotto A Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4171-6. PubMed ID: 17724203 [TBL] [Abstract][Full Text] [Related]
23. Treatment of adenoviral conjunctivitis with topical cidofovir. Gordon YJ; Naesens L; DeClercq E; Maudgal PC; Veckeneer M Cornea; 1996 Sep; 15(5):546. PubMed ID: 8862935 [No Abstract] [Full Text] [Related]
24. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis. Kaufman HE; Varnell ED; Thompson HW Arch Ophthalmol; 1998 Jun; 116(6):777-80. PubMed ID: 9639447 [TBL] [Abstract][Full Text] [Related]
25. HPMPC therapy of MCMV-induced retinal disease in the SCID mouse measured by electroretinography, a non-invasive technique. Garneau M; Bolger GT; Bousquet C; Kibler P; Tremblay F; Cordingley MG Antiviral Res; 2003 Aug; 59(3):193-200. PubMed ID: 12927309 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. De Clercq E Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600 [TBL] [Abstract][Full Text] [Related]
27. In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas. Christensen ND; Pickel MD; Budgeon LR; Kreider JW Antiviral Res; 2000 Nov; 48(2):131-42. PubMed ID: 11114415 [TBL] [Abstract][Full Text] [Related]
28. The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication. Gordon YJ; Araullo-Cruz T; Romanowski EG Arch Ophthalmol; 1998 Jul; 116(7):900-5. PubMed ID: 9682703 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice. Neyts J; De Clercq E J Med Virol; 1993 Nov; 41(3):242-6. PubMed ID: 8263505 [TBL] [Abstract][Full Text] [Related]
30. Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections. Kern ER; Rybak RJ; Hartline CB; Bidanset DJ Antivir Chem Chemother; 2001; 12 Suppl 1():149-56. PubMed ID: 11594682 [TBL] [Abstract][Full Text] [Related]
31. Intravenous Cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient. Carter BA; Karpen SJ; Quiros-Tejeira RE; Chang IF; Clark BS; Demmler GJ; Heslop HE; Scott JD; Seu P; Goss JA Transplantation; 2002 Oct; 74(7):1050-2. PubMed ID: 12394854 [TBL] [Abstract][Full Text] [Related]
33. Effects of phosphonylmethoxyalkyl-purine and -pyrimidine derivatives on TK+ and TK- HSV-1 keratitis in rabbits. Maudgal PC; De Clercq E Antiviral Res; 1991 Jul; 16(1):93-100. PubMed ID: 1663731 [TBL] [Abstract][Full Text] [Related]
34. Effects of phosphonylmethoxyalkyl derivatives studied with a murine model for abortion induced by equine herpesvirus 1. Awan AR; Field HJ Antimicrob Agents Chemother; 1993 Nov; 37(11):2478-82. PubMed ID: 8285638 [TBL] [Abstract][Full Text] [Related]
35. The effect of (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine (HPMPC) on bovine herpesvirus-1 (BHV-1) infection and reactivation in cattle. Gilliam SE; Field HJ Antiviral Res; 1993 Jan; 20(1):21-32. PubMed ID: 8384432 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice. Neyts J; Balzarini J; Naesens L; De Clercq E J Med Virol; 1992 May; 37(1):67-71. PubMed ID: 1320099 [TBL] [Abstract][Full Text] [Related]
37. Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effect. Otová B; Votruba I; Holý A Acta Virol; 1992 May; 36(3):313-9. PubMed ID: 1360759 [TBL] [Abstract][Full Text] [Related]
38. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312 [TBL] [Abstract][Full Text] [Related]
39. Topical effects of cidofovir on cutaneous rabbit warts: treatment regimen and inoculum dependence. Duan J; Paris W; De Marte J; Roopchand D; Fleet TL; Cordingley MG Antiviral Res; 2000 May; 46(2):135-44. PubMed ID: 10854665 [TBL] [Abstract][Full Text] [Related]
40. Cyclopentenylcytosine (CPE-C): In Vitro and In Vivo Evaluation as an Antiviral against Adenoviral Ocular Infections. Romanowski EG; Yates KA; Gordon YJ Molecules; 2023 Jun; 28(13):. PubMed ID: 37446740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]